Concussion Supplements: What Does the Science Actually Support?
A systematic review of 10 supplements for brain recovery after concussion — including the one with 86% symptom resolution in clinical trials, the one that failed its pivotal RCT, and a controversial compound that's a prescription drug in the UK but sold freely in the US.
with NAC (vs 42% placebo)
Systematically Reviewed
with Creatine (Animal Models)
RCTs Completed (Any Supplement)
You've been told to rest, avoid screens, and wait it out. That's still the standard of care for concussion — and it's not wrong. But a growing body of research is asking whether specific nutritional supplements could help the injured brain recover faster, reduce the severity of symptoms, or protect against damage in the first place. We reviewed 40 published studies across 10 supplements to find out which ones actually have evidence behind them.
Why Your Brain Needs More Support After a Concussion
A concussion isn't just a knock to the head — it triggers a neurometabolic crisis that researchers have been mapping for decades. Within seconds of impact, neurons fire uncontrollably, flooding the brain with potassium ions while sodium and calcium rush in. To restore balance, your brain's energy-demanding pumps kick into overdrive, consuming ATP at a rate the injured brain can't sustain.
At the same time, cerebral blood flow drops — meaning less oxygen and glucose arrive precisely when the brain needs more. The result is an energy gap that typically lasts 7–10 days, during which the brain is unusually vulnerable and the characteristic symptoms of concussion (headache, cognitive fog, fatigue, sensitivity to light) are most severe.
This is the therapeutic window that nutritional supplements might be able to target. Different supplements address different parts of this cascade: some act as emergency energy reserves, some reduce inflammation, some repair membrane damage, and some support the brain's antioxidant defences. The question is which of them actually work in human beings.
The Four Main Targets in the Post-Concussion Brain
Energy Crisis
ATP depletion and phosphocreatine loss leave neurons unable to maintain ionic balance. Creatine targets this directly as a phosphocreatine energy buffer.
Oxidative Damage
The surge of calcium and mitochondrial stress generates reactive oxygen species that damage proteins and membranes. NAC replenishes glutathione — the brain's primary antioxidant.
Membrane Disruption
Neuronal membranes are physically torn and chemically disrupted. Omega-3/DHA provides the raw material for membrane repair and the signalling molecules that resolve inflammation.
Neuroinflammation
Microglial activation and cytokine release amplify damage in the days following injury. Multiple supplements — NAC, omega-3, curcumin — target different points of this inflammatory cascade.
The Best-Evidenced Supplements for Concussion
Let's go through the evidence tier by tier, starting with what works best.
Tier 1: Strongest Human Evidence
N-Acetylcysteine (NAC) — The 86% Statistic
NAC is the supplement with the strongest clinical evidence for concussion. In a double-blind, placebo-controlled trial, 81 military personnel with blast-related mild TBI were randomised to NAC (4 g loading dose, then 3 g/day for 7 days) or placebo within 24 hours of injury. At day 7, 86% of the NAC group had complete symptom resolution compared to 42% of placebo — a number needed to treat of 2.3 (Hoffer et al., 2013). Timing was critical: starting NAC within 24 hours of injury was significantly better than delayed treatment. Two additional studies in elderly mTBI patients and chronic mTBI populations confirm the direction of benefit. The main caveat is that the primary evidence comes from military blast injuries, which may differ mechanistically from sport concussion.
Tier 2: Good Evidence — Prophylactic or Biomarker-Level
Omega-3 / DHA — Brain Protection Before (and After) Impact
DHA — the omega-3 fatty acid most concentrated in neuronal membranes — has the best evidence for prophylactic neuroprotection in contact sport athletes. In a randomised trial of 81 American football players, DHA at 2–6 g/day for a full competitive season significantly attenuated serum neurofilament light (Nf-L), a validated biomarker of axonal injury. Higher DHA doses provided greater protection in a dose-dependent pattern. A 2024 meta-analysis confirmed this finding across pooled individual participant data. The evidence is for prevention of subconcussive axonal damage; whether DHA speeds recovery after a diagnosed concussion has not yet been tested in an RCT. The case for taking omega-3/DHA before the season starts is stronger than for starting it post-injury.
Tier 3: Strong Mechanism, Limited Human Trials
Creatine — The Most Compelling Case for More Research
Creatine monohydrate has the most direct mechanistic argument of any supplement on this list. Concussion depletes phosphocreatine (PCr) — the brain's rapid energy reserve — and ³¹P-MRS brain scans in humans confirm this depletion. Creatine supplementation restores PCr stores. Animal TBI models show 36–50% reductions in cortical damage with creatine pre-loading. Two small paediatric pilot studies (Sakellaris 2006, 2008) in children with moderate TBI reported significant reductions in headache, dizziness, fatigue, and cognitive problems at 6 months. The gap is that no well-powered, blinded RCT has tested creatine in adult sport-related concussion. Given creatine's decades-long safety record and the strength of its mechanistic rationale, this is arguably the single most important missing trial in the concussion supplement space.
Hoffer et al. (2013) randomised 81 active-duty military personnel with blast-induced mild TBI to NAC or placebo within 24 hours of injury. NAC arm: 86% symptom resolution at day 7. Placebo arm: 42% resolution. Number needed to treat: 2.3.
What makes this study particularly important: it had a clear primary endpoint (symptom resolution), adequate power, and blinded design. The critical limitation is the population — military blast injuries generate a slightly different injury pattern from sport impacts. The same study in rugby or football players hasn't been done yet.
The Supplements That Promised More Than They Delivered
Two supplements deserve attention not for what they showed, but for what the evidence reveals when you look at it honestly.
Magnesium — The Cautionary Tale
Magnesium was one of the most promising neuroprotective candidates in the 1990s. The preclinical rationale was excellent: TBI depletes brain magnesium, magnesium blocks NMDA receptors (preventing excitotoxic calcium influx), and animal models consistently showed benefit. Then came Temkin et al. (2007) — a multicentre RCT in 499 TBI patients that found no benefit and a trend toward worse outcomes in the higher-dose group. A Cochrane review confirmed: no evidence to support magnesium supplementation for TBI. The probable explanation is that the intact blood-brain barrier in mild TBI prevents systemically administered magnesium from reaching the brain in therapeutic concentrations — an issue that simply isn't present in the animal models where injections can bypass this barrier. This is a critical lesson for the whole field: a powerful preclinical result is not a guarantee of human efficacy.
Melatonin — Effective for Sleep, Not Symptoms
Melatonin's preclinical track record is impressive — a 2019 meta-analysis of 15 animal TBI studies showed a large effect on neurobehavioural outcomes (SMD 1.51). But the PLAYGAME trial — a well-designed, double-blind paediatric RCT of melatonin 3 or 10 mg/day for 4 weeks in 99 children with persistent post-concussive symptoms — found no significant improvement in symptom scores versus placebo. Melatonin does appear to improve sleep quality after TBI (Grima et al., 2018), and sleep disruption is one of the most impactful symptoms in the post-concussion period. So while melatonin shouldn't be discarded as a concussion supplement, its value may be primarily as a sleep aid rather than a neuroprotective intervention.
The Full Evidence Picture at a Glance
Vinpocetine: The Supplement That Isn't a Supplement in the UK
Vinpocetine deserves a section of its own, because it's one of the more unusual stories in the concussion supplement space.
Derived from the lesser periwinkle plant (Vinca minor), vinpocetine is a PDE1 inhibitor that increases cerebral blood flow, blocks NF-kB-driven neuroinflammation, and modulates the NMDA receptors that drive excitotoxic damage after head injury. Two recent animal studies — using cold-injury and weight-drop TBI models respectively — showed significant, dose-dependent improvements in brain swelling, neuronal survival, cognitive function, and inflammation markers. The preclinical case is genuinely interesting.
The problem is threefold. First, there's almost no human evidence — just one small, non-randomised comparative study in 90 head injury patients that showed promising functional recovery scores but had major methodological limitations. Second, and more practically important for UK and European readers: vinpocetine is not legally available as a food supplement in the UK or EU. It's classified as a prescription pharmaceutical drug (sold as Cavinton in most EU member states). UK law follows the assimilated EU framework that treats it as a pharmaceutical substance — not a supplement.
United Kingdom: Not authorised as a food supplement. Treated as a pharmaceutical substance. Not available OTC.
European Union: Prescription drug (Cavinton) in most member states. Not approved in food supplements by EFSA. Requires a prescription.
United States: Contested. FDA tentatively concluded in 2016 that it doesn't qualify as a dietary ingredient; a 2019 FDA safety alert warned of reproductive harm. Despite this, 387+ commercial products still sell it. On the US military's prohibited supplement list. No final enforcement ruling.
If you see vinpocetine sold as a supplement in the UK or EU, the product may be non-compliant with local food law.
What Should a Contact Sport Athlete Actually Take?
Based on the current evidence, here's where the science meaningfully supports supplementation — and where it doesn't.
| Supplement | When | Dose | Rationale |
|---|---|---|---|
| Omega-3 / DHA | Year-round (especially in-season) | 2–6 g DHA/day | Best evidence for prophylactic axonal protection in contact sport. Start before the season. |
| Creatine | Year-round | 3–5 g/day (no loading required) | Pre-loads the PCr energy system that concussion depletes. Decades of safety data. Dual performance and neuroprotection rationale. |
| NAC | Immediately post-concussion (within 24 h if possible) | 4 g loading, then 3 g/day for 7 days | Only supplement with strong RCT evidence for post-injury symptom resolution. Best started early. |
| Melatonin | Post-concussion if sleep is disrupted | 3–10 mg at bedtime | Well-evidenced for sleep quality in TBI. Sleep is critical for neurological recovery. |
This protocol is not a treatment recommendation — it's a summary of what the published evidence currently suggests. Always consult a sports medicine physician or concussion specialist after a head injury. Return-to-sport decisions should never be influenced by supplement use.
The Honest Bottom Line
This is a field where the science is genuinely interesting but the human evidence is thin. NAC has the best single-study result in concussion supplement research — but one military trial in blast-injury patients is not the same as evidence for your rugby player. Omega-3/DHA has the best prophylactic data. Creatine has the best mechanistic rationale waiting for the right clinical trial. And magnesium is a cautionary reminder that preclinical promise doesn't always translate.
The one clear message: no supplement replaces rest, proper medical evaluation, and a graded return-to-sport protocol. These are adjuncts to good management — not shortcuts around it.
Access the Full Research
Our clinical research team has produced full evidence-graded documents available for download, formatted for clinicians, healthcare professionals, and informed patients.
Nutritional Supplements for Concussion and mTBI Recovery — Systematic Narrative Review
Full multi-supplement systematic review: 10 supplements, 40+ studies, evidence grading, mechanism analysis, and vinpocetine regulatory analysis.
↓ Download Research PaperSupplements for Concussion/mTBI — Clinical Evidence Summary
Concise clinical reference: evidence grades, dosing, key studies, and safety profile for all 10 supplements. Designed for quick clinical reference.
↓ Download Clinical One-PagerEvidence-Informed Recovery Starts Here
Explore our range of sports recovery supplements — formulated at clinically-studied doses, with transparent sourcing and full research backing.
Shop Recovery Products →Published Research References
- Giza CC, Hovda DA. The neurometabolic cascade of concussion. J Athl Train. 2001;36(3):228–235.
- Hoffer ME, Balaban C, Slade MD, et al. Amelioration of acute sequelae of blast induced mild traumatic brain injury by N-acetyl cysteine: a double-blind, placebo controlled study. PLoS ONE. 2013;8(1):e54163.
- Oliver JM, Jones MT, Kirk KM, et al. Effect of docosahexaenoic acid on a biomarker of head trauma in American football. Med Sci Sports Exerc. 2016;48(6):974–982.
- Lust CAC, et al. Nutritional optimization for brain health in contact sports: a systematic review and meta-analysis. J Nutr. 2024 (online).
- Sullivan PG, et al. Dietary supplement creatine protects against traumatic brain injury. Ann Neurol. 2000;48(5):723–729.
- Sakellaris G, et al. Prevention of complications related to traumatic brain injury in children with creatine. J Trauma. 2006;61(2):322–329.
- Lyoo IK, et al. Multinuclear MRS of high-energy phosphate metabolites following TBI. Am J Psychiatry. 2003;160(12):2221–2227.
- Kreider RB, et al. ISSN position stand: safety and efficacy of creatine supplementation. J Int Soc Sports Nutr. 2017;14:18.
- Temkin NR, et al. Magnesium sulfate for neuroprotection after TBI: a randomised controlled trial. Lancet Neurol. 2007;6(1):29–38.
- Arango MF, Bainbridge D. Magnesium for acute TBI. Cochrane Database Syst Rev. 2008;(4):CD005400.
- Barlow KM, et al. Melatonin for post-concussion symptoms in children (PLAYGAME): a randomised controlled trial. Lancet Child Adolesc Health. 2020;4(8):597–609.
- Barlow KM, et al. Melatonin as a treatment after TBI: a systematic review and meta-analysis. J Neurotrauma. 2019;36(4):523–537.
- Zhang Y, et al. Vinpocetine ameliorates neuronal injury after cold-induced TBI in mice. Brain Res Bull. 2024. PMID: 39361199.
- El-Sayed RM, et al. Vinpocetine restores cognitive and motor functions in TBI challenged rats. Inflammopharmacology. 2022;30(6):2457–2468.
- FDA Safety Alert: Vinpocetine and reproductive harm. 2019. US Food and Drug Administration.